BioCorRx BICX
OTC BICX
$0.20 -0.01 (-4.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioCorRx (BICX) Asset Writedowns and Impairment (2023)

Updated

BioCorRx (BICX) posted Asset Writedowns and Impairment of $47,980 for FY2023.

Analysis

BioCorRx (BICX) Asset Writedowns and Impairment (2023) Analysis & Trends

  • Annual Asset Writedowns and Impairment shows a five-year compound annual growth rate of -28.1% (FY2018 to FY2023).
  • Business Quant data shows BICX's Asset Writedowns and Impairment at $141,480 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 BioCorRx 3.46 Mn 2.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 47,980.00
API Access

BioCorRx Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=BICX&period=max&api_key=YOUR_API_KEY